Skip to main content
Clinical Trials/CTRI/2022/09/045374
CTRI/2022/09/045374
Not yet recruiting
未知

Clinical Performance Evaluation and Validation study for diagnostic accuracy (sensitivity and specificity) of PanTum Detect blood test

Millennium Oncology India Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Millennium Oncology India Private Limited
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Millennium Oncology India Private Limited

Eligibility Criteria

Inclusion Criteria

  • Written informed consent.
  • \-Consent to undergo PET/CT examination in specific study centers in case of a positive index test result of a healthy subject.
  • \-Healthy controls: Age 30\-75 years.
  • \-Sick population: Histopathology/Cytology proven diagnosis.

Exclusion Criteria

  • \-Tumor\-related treatment in last 3 months (i.e. Chemotherapy, Radiotherapy, Immunotherapy, Hormone therapy treatment, Surgery etc.)
  • \-History of taking any of the following drugs in last 08 week:
  • i. Corticosteroid containing drugs
  • ii. Immunosuppressants (Methotrexate, Cyclosporine, Azathioprine, Tacrolimus, Mycophenolate, Rapamycin, Sirolimus, Adalimumab, Infliximab etc.) :
  • iii. GMCSF (Sargramostim)
  • \-History of severe febrile illness or inflammation during the last 8 weeks before blood draw
  • \-History of Covid during the last 8 weeks
  • \-History of any vaccination during preceding 4 weeks
  • \-History of any surgery or severe trauma during last 8 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials